Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05865> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05865 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05865 label "VIT-100 [drugbank:DB05865]" assertion.
- drugbank:DB05865 seeAlso DB05865 assertion.
- drugbank:DB05865 description "VIT-100 was developed by ItherX Pharmaceuticals of San Diego. In preclinical studies, companyl has shown that VIT-100 inhibits the growth of cells taken from multiple keloid biopsies as compared to the same keloidal cells treated with a control. It is believed that similar effects would be seen in cells isolated from hypertrophic scars." assertion.
- drugbank:DB05865 identifier "drugbank:DB05865" assertion.
- drugbank:DB05865 title "VIT-100" assertion.
- drugbank:DB05865 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05865 drugbank_vocabulary:drugbank-id "DB05865" assertion.
- drugbank:DB05865 bio2rdf_vocabulary:x-identifiers.org DB05865 assertion.
- drugbank:DB05865 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05865" assertion.
- drugbank:DB05865 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05865 bio2rdf_vocabulary:identifier "DB05865" assertion.